These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38456579)

  • 41. Association of Glycemic Control With Reduced Risk for Large-Vessel Disease After More Than 50 Years of Type 1 Diabetes.
    Tinsley LJ; Kupelian V; D'Eon SA; Pober D; Sun JK; King GL; Keenan HA
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3704-3711. PubMed ID: 28973526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.
    Yu D; Shang J; Cai Y; Wang Z; Zhang X; Zhao B; Zhao Z; Simmons D
    BMJ Open Diabetes Res Care; 2019; 7(1):e000735. PubMed ID: 31798896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark.
    Larsen MB; Henriksen JE; Grauslund J; Peto T
    Acta Ophthalmol; 2017 Dec; 95(8):778-786. PubMed ID: 28444837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR).
    Zethelius B; Eliasson B; Eeg-Olofsson K; Svensson AM; Gudbjörnsdottir S; Cederholm J;
    Diabetes Res Clin Pract; 2011 Aug; 93(2):276-284. PubMed ID: 21719139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).
    Pease A; Earnest A; Ranasinha S; Nanayakkara N; Liew D; Wischer N; Andrikopoulos S; Zoungas S
    Cardiovasc Diabetol; 2018 Jun; 17(1):77. PubMed ID: 29859534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
    Wadén J; Forsblom C; Thorn LM; Gordin D; Saraheimo M; Groop PH;
    Diabetes; 2009 Nov; 58(11):2649-55. PubMed ID: 19651819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Joint effects of physical frailty and traditional cardiovascular risk factor control on cardiovascular disease in patients with diabetes.
    Li J; Li J; Yu Y; Sun Y; Yu B; Shen W; Cai L; Wang N; Wang B; Lu Y
    J Nutr Health Aging; 2024 Oct; 28(10):100342. PubMed ID: 39180942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes.
    Vistisen D; Andersen GS; Hulman A; McGurnaghan SJ; Colhoun HM; Henriksen JE; Thomsen RW; Persson F; Rossing P; Jørgensen ME
    Diabetes Care; 2021 Apr; 44(4):901-907. PubMed ID: 33509931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progression of Electrocardiographic Abnormalities in Type 1 Diabetes During 16 Years of Follow-up: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Soliman EZ; Backlund JY; Bebu I; Li Y; Zhang ZM; Cleary PA; Lachin JM;
    J Am Heart Assoc; 2016 Mar; 5(3):e002882. PubMed ID: 26976878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes.
    Nyström T; Holzmann MJ; Eliasson B; Svensson AM; Sartipy U
    Diabetes Obes Metab; 2018 Mar; 20(3):556-563. PubMed ID: 28884949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes.
    Gordin D; Harjutsalo V; Tinsley L; Fickweiler W; Sun JK; Forsblom C; Amenta PS; Pober D; D'Eon S; Khatri M; Stillman IE; Groop PH; Keenan HA; King GL
    Diabetes Care; 2018 Apr; 41(4):815-822. PubMed ID: 29386250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes.
    Hero C; Rawshani A; Svensson AM; Franzén S; Eliasson B; Eeg-Olofsson K; Gudbjörnsdottir S
    Diabetes Care; 2016 Jun; 39(6):996-1003. PubMed ID: 27208327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the new zealand diabetes cohort study.
    Elley CR; Robinson E; Kenealy T; Bramley D; Drury PL
    Diabetes Care; 2010 Jun; 33(6):1347-52. PubMed ID: 20299482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
    Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
    J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of 10-year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning-based methods.
    Dong W; Wan EYF; Fong DYT; Tan KC; Tsui WW; Hui EM; Chan KH; Fung CSC; Lam CLK
    Diabetes Obes Metab; 2024 Sep; 26(9):3969-3987. PubMed ID: 39010291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Rawshani A; Rawshani A; Sattar N; Franzén S; McGuire DK; Eliasson B; Svensson AM; Zethelius B; Miftaraj M; Rosengren A; Gudbjörnsdottir S
    Circulation; 2019 Apr; 139(16):1900-1912. PubMed ID: 30798638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Schade D; Braffett B; Kosiborod M; Lopes-Virella M; Soliman EZ; Herman WH; Bluemke DA; Wallia A; Orchard T; Lachin JM;
    Diabetes Care; 2020 Apr; 43(4):867-874. PubMed ID: 32001614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study.
    Elley CR; Kenealy T; Robinson E; Drury PL
    Diabet Med; 2008 Nov; 25(11):1295-301. PubMed ID: 19046219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.